Tocerapet is a veterinary antineoplastic medication containing toceranib, an analogue of Palladia based on the same active ingredient. It belongs to the class of tyrosine kinase inhibitors and is used to treat mast cell tumors in dogs as prescribed by a veterinarian.
Composition: Toceranib.
Available strengths:
-
10 mg of toceranib per tablet.
-
50 mg of toceranib per tablet.
Directions for use: Oral administration. The dosage, frequency of administration, and duration of treatment are determined individually by a veterinarian.
Contraindications: Hypersensitivity to the ingredients, gastrointestinal bleeding, pregnancy, and lactation. Do not use in dogs under 2 years of age or weighing less than 3 kg, or in animals intended for breeding.
Important: Use only under veterinary supervision with regular blood test monitoring.
